Using monopolar radiofrequency energy, it heats and destroys fat cells beneath the skin without needles, surgery, or downtime
They slow gastric emptying, change bile acid composition, and affect the gut microbiome
This happens when the GLP-1 drugs cause nerve and muscle damage to the stomach muscles, which stops food from moving through the gastrointestinal system
On average, clients covering GLP-1 drugs for weight loss would have seen potential savings of 28% by moving to the Collective Health + Noom Med with SmartRx program*
The safety profile was consistent with GLP-1 receptor agonists, primarily featuring transient, mild-to-moderate gastrointestinal adverse events (e.g., nausea, 55%), with low discontinuation rates (6-8.4%)